AmplifAI Raises $33.7M to Power High-Performing Human Teams and AI Agents Driving the Future of Customer Experience

PLANO, Texas--(BUSINESS WIRE)--AmplifAI, the leading AI-powered platform transforming enterprise contact center performance, today announced it has raised $33.7M in Series B funding and credit facility. The round was led by CVS Health Ventures, with participation from existing investors LiveOak Ventures and Dallas Venture Partners. This investment will accelerate AmplifAI’s mission to unify human and AI agent performance and deliver best-in-class customer experience at scale.

With growing pressure on contact centers to reduce costs while strengthening customer loyalty, retention, and sales, AmplifAI is reimagining the contact center using an AI first approach. The platform ensures that human agents focus on complex, high-value interactions while AI agents seamlessly manage routine contacts. By unifying both human and AI performance in one platform, AmplifAI transforms conversations and workflows across every level of the contact center, delivering efficiency, empathy, and measurable outcomes.

“AmplifAI’s capabilities are bringing greater consistency and effectiveness to call center operations by giving leaders clear insight into behaviors and practices that drive success,” said Vijay Patel, CVS Health Ventures. “These insights enable organizations to identify skill gaps, tailor coaching to individual agents, and scale best practices across teams, meaningfully elevating the customer experience.”

AmplifAI’s platform unifies customer surveys, voice recordings, chat, and chatbot conversations with metrics, behavioral data, contact reasons, and systemic product or process issues. By applying generative AI to this multi-channel data, AmplifAI not only uncovers hidden customer pain points but also generates real-time coaching, workflows, and automated actions. This approach reduces friction, strengthens loyalty, and drives measurable business results.

“We are reimagining the contact center with human-centric AI—empowering people to be more effective while virtual agents reduce costs, together delivering an optimal customer experience,” said Sean Minter, CEO of AmplifAI. “AmplifAI enables midmarket and Fortune 500 companies across healthcare, financial services, communications/technology, and retail to elevate performance and deliver best-in-class customer experiences.”

Since its founding in 2018, AmplifAI has partnered with leading brands across retail, healthcare, financial services, and tech, delivering measurable impact, including: increasing sales conversion by over 100%, reducing cost per contact by nearly 10% and improving resolution rates by over 20%. AmplifAI was also recognized as a Cool Vendor by Gartner in 2024 and as a Leading Pioneer in the Automated QA/QM Prism by CMP Research.

To learn more about AmplifAI, please visit https://amplifai.com

About AmplifAI

AmplifAI is an AI-powered platform for contact center performance analytics that helps organizations optimize their workforce by ensuring agents focus on complex, high-value interactions while AI seamlessly manages simpler contacts. By transforming raw interaction data into actionable insights, AmplifAI enables enterprises to enhance customer experience, increase agent effectiveness, improve AI Agent performance and drive operational efficiency.

About CVS Health Ventures

CVS Health Ventures is a dedicated corporate venture capital fund that works with high-potential, early-stage and growth-stage companies focused on making health care more accessible, affordable, and simpler. The company focuses on investments that transform care delivery and focus on whole person care, consumer-centric health, and disruptive technology enablement. CVS Health Ventures’ goal is to enable promising entrepreneurs to scale more quickly and effectively through access to their unmatched enterprise capabilities and consumer touchpoints, while offering expertise and insights from their company’s unique perspective. For more information, visit cvshealthventures.com